Agilon Health
About: Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
Employees: 1,076
0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
51% more call options, than puts
Call options by funds: $5.23M | Put options by funds: $3.46M
7% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 57
3.04% less ownership
Funds ownership: 104.03% [Q3] → 100.99% (-3.04%) [Q4]
13% less funds holding
Funds holding: 211 [Q3] → 184 (-27) [Q4]
36% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 58
50% less funds holding in top 10
Funds holding in top 10: 2 [Q3] → 1 (-1) [Q4]
53% less capital invested
Capital invested by funds: $1.68B [Q3] → $791M (-$891M) [Q4]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$3
30%
downside
Avg. target
$5.17
21%
upside
High target
$8.50
100%
upside
6 analyst ratings
3 positive
50%
3 neutral
50%
0 negative
0%
Citigroup Daniel Grosslight 38% 1-year accuracy 9 / 24 met price target | 17%upside $5 | Buy Upgraded | 25 Apr 2025 |
TD Cowen Ryan Langston 0% 1-year accuracy 0 / 10 met price target | 41%upside $6 | Hold Maintained | 15 Apr 2025 |
Baird Michael Halloran 10% 1-year accuracy 3 / 30 met price target | 17%upside $5 | Neutral Maintained | 15 Apr 2025 |
Bernstein Amir Farahan 0% 1-year accuracy 0 / 1 met price target | 100%upside $8.50 | Outperform Upgraded | 8 Apr 2025 |
RBC Capital Sean Dodge 36% 1-year accuracy 12 / 33 met price target | 18%downside $3.50 | Outperform Maintained | 26 Feb 2025 |
Financial journalist opinion
Based on 3 articles about AGL published over the past 30 days
Neutral
Seeking Alpha
2 weeks ago
Bloodied But Unbowed, Agilon Health Can Profit From Improving Market Dynamics
agilon health's stock has surged over 165% YTD in 2025 despite a 77% decline since its 2021 IPO, driven by CMS rate hikes for 2026. The company faces challenges with significant operating losses and industry headwinds, but remains committed to value-based care over fee-for-service models. agilon's business model involves global capitation fees from health plan payors, focusing on Medicare Advantage through a network of physician partners.
Positive
Zacks Investment Research
3 weeks ago
Agilon (AGL) Moves 26.1% Higher: Will This Strength Last?
Agilon (AGL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Neutral
Business Wire
3 weeks ago
agilon health to Participate in BofA Securities 2025 Health Care Conference
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the BofA Securities 2025 Health Care Conference including a fireside chat presentation on Wednesday, May 14 at 1:00 PM Eastern Time. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the “Events & Presentations” section of agilon health's inve.
Neutral
Business Wire
1 month ago
agilon health Sets Date to Report First Quarter 2025 Financial Results
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2025 after the market closes on Tuesday, May 6, 2025, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international pa.
Positive
Zacks Investment Research
1 month ago
Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?
Here is how Agilon Health (AGL) and Paragon 28, Inc. (FNA) have performed compared to their sector so far this year.
Neutral
Benzinga
1 month ago
Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals
J.P. Morgan analyst Lisa C. Gill, with a Neutral rating, updated estimates for Agilon Health, Inc. AGL following fourth-quarter results posted last month.
Positive
Zacks Investment Research
1 month ago
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?
Here is how Agilon Health (AGL) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year.
Neutral
Seeking Alpha
2 months ago
agilon health, inc. (AGL) Q4 2024 Earnings Call Transcript
agilon health, inc. (NYSE:AGL ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Justin Lake - Wolfe Research Jack Slevin - Jefferies Ryan Langston - TD Cowen Amir Farahani - Bernstein Jailendra Singh - Truist Securities Michael Ha - Baird Elizabeth Anderson - Evercore Adam Ron - Bank of America Ryan Daniels - William Blair Whit Mayo - Leerink Partners Daniel Grosslight - Citi David Larsen - BTIG George Hill - Deutsche Bank Matt Shea - Needham Operator Hello and welcome to the agilon health Fourth Quarter 2024 Earnings Conference.
Neutral
Zacks Investment Research
2 months ago
Agilon (AGL) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Negative
Zacks Investment Research
2 months ago
Agilon Health (AGL) Reports Q4 Loss, Tops Revenue Estimates
Agilon Health (AGL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.41 per share a year ago.
Charts implemented using Lightweight Charts™